In 2018, 16 chairmen of pharmaceutical companies resigned

[China Pharmaceutical network industry news] on November 9, Zhejiang Haizheng Pharmaceutical Co., Ltd (hereinafter referred to as "Haizheng pharmaceutical") issued the announcement on the resignation of the chairman of the board Mr Bai Hua, chairman of Haizheng pharmaceutical, resigned as chairman of the seventh board of directors, director, member of Nomination Committee and standing member of Expert Committee due to age and physical reasons, and no longer served as the legal representative of the company After his resignation, Mr Baihua will not hold any post in the company Baihua is the "soul" of Haizheng pharmaceutical Baihua's resignation also means the end of an era of Haizheng pharmaceutical and the coming of a new era 2018 is coming to an end This year, a number of chairman or acting chairman of the pharmaceutical industry announced their resignation According to relevant statistics, up to now, there have been 16 resignations In January, two pharmaceutical companies resigned On January 2, Anhui Limin Biotechnology Co., Ltd announced that the board of directors of the company received the resignation report submitted by Mr Wu kindan, chairman of the board of directors on December 29, 2017 On January 18, Shandong Keyuan Pharmaceutical Co., Ltd announced that the board of directors of the company received the resignation report submitted by Chairman Zhang Zhongshan on January 16, 2018 In February, an executive of a pharmaceutical company resigned On February 12, Jiangsu Bikang Pharmaceutical Co., Ltd issued a notice that the board of directors of the company received a written resignation report from Mr Zhou Xinji, chairman of the board of directors of the company on February 12, 2018 Mr Zhou Xinji applied to resign as chairman of the company, and resigned as chairman of the Strategy Committee and member of the remuneration and evaluation committee of the board of directors After resignation, he still served as a director of the company Position and position in subsidiaries In March, four senior executives of pharmaceutical companies resigned On March 5, Beijing Saifu Pharmaceutical Co., Ltd issued a notice saying that the board of directors of the company received the resignation report submitted by Mr Du Haiyue, the director, chairman and general manager of the company and legal representative, on March 1, 2018 On March 7, Hunan Huakang Biotechnology Co., Ltd announced that the board of directors had received the resignation report submitted by Mr Li xiuran, the director, chairman and general manager, and legal representative, on March 6, 2018 On March 27, Jiangzhong Pharmaceutical Co., Ltd announced that the board of directors had recently received a written resignation report from Mr Zhong Hongguang, chairman of the company On March 22, Tianjin TIANYAO Pharmaceutical Co., Ltd issued a notice that the board of directors received the written resignation report submitted by Mr Chen Jian, chairman and general manager of the company on March 22, 2018 In April, June and July, a senior manager of a pharmaceutical company resigned On April 26, Hangzhou Kangyun Biotechnology Co., Ltd issued a notice saying that the board of directors of the company received the resignation report submitted by Jin Jianying, vice chairman of the board of directors on March 12, 2018 On June 29, Suzhou southeast Pharmaceutical Co., Ltd announced that the board of directors had received the resignation report submitted by the chairman and legal representative Ms Zhan Xiaozhou on June 27, 2018, and resigned from the position of chairman On July 5, Chongqing Shengao Biochemical Pharmaceutical Co., Ltd issued a notice that the board of directors of the company received the resignation report submitted by Mr Gong Zhiguo, director, chairman and general manager on July 5, 2018 In August, two drug executives resigned On August 7, Hengkang medical group announced that the board of directors of the company had recently received a written resignation report from Mr Zhou Xianmin, the chairman of the board of directors Due to physical reasons, Mr Zhou Xianmin applied to resign from the corresponding positions of the Fourth Board of directors, the chairman of the board, the strategy committee and the audit committee of the board of directors After resignation, Mr Zhou Xianmin will not hold any positions in the company On August 27, Inner Mongolia runzeyuan Biotechnology Co., Ltd issued a notice that the board of directors of the company received the resignation report submitted by Chairman Li Yinghui on August 24, 2018 In September and October, a senior manager of a pharmaceutical enterprise resigned On September 21, Guanfu Holding Co., Ltd issued a notice and received the written resignation report submitted by Mr Lin Wenchang on September 20, 2018 On October 15, Zhuhai Rundu Pharmaceutical Co., Ltd issued a notice and received the written resignation report of chairman Li Xi on October 13, 2018.